1. Abrams, P. G., Knost, J. A., Clarke, G., Wilburn, S., Oldham, R. K., and Foon, K. A., 1983, Determination of the optimal human cell lines for development of human hybridomas, J. Immunol. 131: 1201–1204.
2. Astaldi, G. C. B., Wright, E. P., Willems, C. H., Zeijlemaker, W. P., and Janssen, M. C., 1982, Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM, J. Immunol. 128: 2539–2542.
3. Brown, N. A., and Miller, G., 1982, Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein—Barr virus, J. Immunol. 128: 24–29.
4. Buck, D. W., Larrick, J. W., Raubitschek, A., Truitt, K., Senyk, G., Wang, J., and Dyer, B. J., 1984, Production of human monoclonal antibodies, in: Monoclonal Antibodies and Functional Cell Lines ( R. H. Kennett, K. Bectol, and T. J. McKearn, eds.), Plenum Press, New York, pp. 275–309.
5. Butler, J. L., Lane, H. C., and Fauci, A. S., 1983, Delineation of optimal conditions for producing mouse/human heterohybridomas from human peripheral blood B cells of immunized subjects, J. Immunol. 130: 165–168.